Lineage Cell Therapeutics (LCTX) Gross Profit Growth (1y) (2012 - 2026)
Lineage Cell Therapeutics (LCTX) Gross Profit Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 75.94% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.76% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Lineage Cell Therapeutics | 303.84 Mn | 239.94 Mn | 1.73 Mn | 17.67% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.67% |
| Dec 31, 2025 | 141.05% |
| Sep 30, 2025 | -1.74% |
| Jun 30, 2025 | 99.85% |
| Mar 31, 2025 | 8.92% |
| Dec 31, 2024 | 48.14% |
| Sep 30, 2024 | 247.35% |
| Jun 30, 2024 | -55.97% |
| Mar 31, 2024 | -40.63% |
| Dec 31, 2023 | 1.05% |
| Sep 30, 2023 | -61.02% |
| Jun 30, 2023 | -28.58% |
| Mar 31, 2023 | -55.21% |
| Dec 31, 2022 | 88.07% |
| Sep 30, 2022 | 115.02% |
| Jun 30, 2022 | 1,020.93% |
| Mar 31, 2022 | 1,713.98% |
| Dec 31, 2021 | 300.00% |
| Sep 30, 2021 | 173.99% |
| Jun 30, 2021 | 24.44% |